Amring Pharmaceuticals Inc.

Amring is committed to putting people first in all it does, providing high quality generic medications and excellent customer service at a reasonable cost.

We may be new to the marketplace, but we are supported by a trusted, privately held, global pharmaceutical company with a 65-year history of quality, value and success. Amring Pharmaceuticals Inc. builds on this stellar legacy, while also distinguishing ourselves as a multinational resource for reliable generic medications and a sustainable global business in our own right.

As a private company focused on supplying unique and specialized products in targeted markets, we offer a simple value proposition to our customers, our partners and the pharmaceutical marketplace: We leverage every opportunity to meet specific customer demands with value-added generic medicines. Our customer service is second to none, as we are a tight, well-connected group that is able to respond quickly to requests from both our customers and partners.

We have strategically positioned ourselves to make and market affordable products that add value. We are already invested in Desmopressin Acetate, a peptide-based drug that can treat indications such as diabetes insipidus as well as certain bleeding disorders and bedwetting problems, and Tranexamic Acid, a product for the treatment of certain bleeding disorders in women. We are actively seeking to add more products to our portfolio.

Amring is run by a leadership team whose members bring significant experience in generic pharmaceuticals and related industries. We are senior pharmaceutical executives with proven success in growing businesses from the ground up, a keen ability to quickly maximize global resources at a local level, and the commitment and experience to support long-term sustainable relationships. Our broad capabilities can also fill the gaps in pharmaceutical development, manufacturing, marketing and distribution.

Backed by a notable heritage of accomplishment in the pharmaceutical industry, we look forward to growing Amring in the years ahead, and bringing more high-quality, dependable generic pharmaceutical products to the marketplace.